default author photo

Yuji Minegishi

Nippon Medical School - Department of Pulmonary Medicine and Oncology

Tokyo

Japan

  • Nippon Medical School - Department of Pulmonary Medicine and Oncology

SCHOLARLY PAPERS

3

DOWNLOADS

155

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Real-World Outcomes of Chemotherapy for Lung Cancer Patients Undergoing Hemodialysis: A Multicenter Retrospective Cohort Study (NEJ-042)

Number of pages: 13 Posted: 12 Apr 2022
Yuji Minegishi, Tomoe Akagami, Makoto Arai, Ryota Saito, Daisuke Arai, Kyoko Murase, Keita Miura, Satoshi Watanabe, Hiroyuki Sakashita, Takao Miyabayashi, Ryoichi Honda, Daisuke Jingu, Takamasa Hotta, Kazutoshi Isobe, kensuke Nakazawa, Kenichiro Ito, Kei Takamura, Minehiko Inomata, Toshiyuki Harada, Rie Sakakibara, Taku Nakagawa, Hideki Shibuya, Kiyoshi Takenaka, Kunihiko Kobayashi and Masahiro Seike
Nippon Medical School - Department of Pulmonary Medicine and Oncology, affiliation not provided to SSRN, affiliation not provided to SSRN, Tohoku University - Tohoku University Hospital, Saiseikai Utsunomiya Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, Niigata University - Medical and Dental Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, Soochow University - Department of Respiratory Medicine, Soochow University - Department of Respiratory Medicine, Shimane University - Division of Medical Oncology and Respiratory Medicine, Toho University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Toyama, Hokkaido University Hospital - Division of Laboratory and Transfusion Medicine, Tokyo Medical and Dental University, Omagari Kosei Medical Center-Department of Thoracic Surgery, affiliation not provided to SSRN, Soochow University - Department of Respiratory Medicine, affiliation not provided to SSRN and Nippon Medical School - Department of Pulmonary Medicine and Oncology
Downloads 77 (830,555)

Abstract:

Loading...

Small cell lung cancerNon-small cell lung cancerEnd-stage renal diseaseChronic kidney diseaseHemodialysisChemotherapyEGFR-tyrosine kinase inhibitors

2.

A Randomized Phase Ii Trial of Standard Versus Low-Dose Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Cancer: JMTO LC14-01

Number of pages: 24 Posted: 07 Apr 2022
Susumu Takeuchi, Kaoru Kubota, Shunichi Sugawara, Satoshi Teramukai, Rintaro Noro, Kei Fujikawa, Takashi Hirose, Shinji Atagi, Seigo Minami, Shinichiro Iida, Hiroshi Kuraishi, Tomoiki Aiba, Yuji Minegishi, Masaru Matsumoto, Masahiro Seike, Akihiko Gemma and Masaaki Kawahara
Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Sendai Kousei Hospital - Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine - Department of Biostatistics, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Kyoto Prefectural University of Medicine - Department of Biostatistics, Nippon Medical School - Department of Pulmonary Medicine, National Hospital Organization - Department of Thoracic Oncology, Osaka Police Hospital - Department of Respiratory Medicine, Otemae Hospital - Department of Pulmonary Medicine, Nagano Red Cross Hospital - Department of Pulmonary Medicine, Sendai Kousei Hospital - Department of Pulmonary Medicine, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology and The Japan-Multinational Trial Organization (JMTO)
Downloads 40 (1,196,171)

Abstract:

Loading...

Non-small cell lung cancer, nab-paclitaxel, Low dose, Phase 2

3.

Randomized Phase II Trial of Standard Versus Low-Dose Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung Cancer: JMTO LC14-01

Number of pages: 34 Posted: 25 Nov 2021
Susumu Takeuchi, Kaoru Kubota, Shunichi Sugawara, Satoshi Teramukai, Rintaro Noro, Kei Fujikawa, Takashi Hirose, Shinji Atagi, Seigo Minami, Shinichiro Iida, Hiroshi Kuraishi, Tomoiki Aiba, Yuji Minegishi, Masaru Matsumoto, Masahiro Seike, Akihiko Gemma and Masaaki Kawahara
Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Sendai Kousei Hospital - Department of Pulmonary Medicine, Kyoto Prefectural University of Medicine - Department of Biostatistics, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Kyoto Prefectural University of Medicine - Department of Biostatistics, Nippon Medical School - Department of Pulmonary Medicine, National Hospital Organization - Department of Thoracic Oncology, Osaka Police Hospital - Department of Respiratory Medicine, Otemae Hospital - Department of Pulmonary Medicine, Nagano Red Cross Hospital - Department of Pulmonary Medicine, Sendai Kousei Hospital - Department of Pulmonary Medicine, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Nippon Medical School - Department of Pulmonary Medicine and Oncology and The Japan-Multinational Trial Organization (JMTO)
Downloads 38 (1,209,354)

Abstract:

Loading...

nab-paclitaxel, optimal dose, advanced NSCLC